Offerings // InMed Pharmaceuticals Inc.

INM offering history

Every offering-related filing in InMed Pharmaceuticals Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 492 filings back to Jan 17, 2018.

Last executed offering

Apr 3, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Mar 20, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Apr 3, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 30, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 20, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 5, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 1, 2025	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Aug 1, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 9, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 30, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 2, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 31, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 30, 2024	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Dec 23, 2024	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Dec 18, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 17, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 28, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 13, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 13, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 8, 2023	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 30, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 15, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 14, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 7, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Nov 22, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 19, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 18, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 12, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 14, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 6, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 29, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 24, 2022	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 21, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 6, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 6, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 1, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 25, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

INM offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full INM workspace →

INM offering FAQ

When did INM last execute an offering?

Per SEC filings, InMed Pharmaceuticals Inc.'s most recent priced offering document is a 424B5 filed 2026-04-03. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did INM last announce or register an offering?

The most recent registration is a S-3 filed 2026-03-20. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.